Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

EU Says The Value Of Its Research Programs 'Hazy'

Jan. 2, 2008

By Peter O'Donnell

EU Says The Value Of Its Research Programs 'Hazy'

Jan. 2, 2008

By Peter O'Donnell

EU Moving to Tighten Rules On Flow Of Drug Information

Dec. 26, 2007

By Peter O'Donnell

EU Moving to Tighten Rules On Flow Of Drug Information

Dec. 26, 2007

By Peter O'Donnell

One Step Forward for Small European Firms In Biotech

Dec. 19, 2007

By Peter O'Donnell

One Step Forward for Small European Firms In Biotech

Dec. 19, 2007

By Peter O'Donnell

Lithuania Under Fire For Biogeneric Drug

Dec. 12, 2007

By Peter O'Donnell

Lithuania Under Fire For Biogeneric Drug

Dec. 12, 2007

By Peter O'Donnell

European Generic Firms Mount Biosimilars Push

Dec. 5, 2007

By Peter O'Donnell

European Biotech Industry Goes On GMO Offensive

Dec. 5, 2007

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...